GDF15 induces excessive activation of osteoclasts within the vertebral endplates leading to early endplate degeneration
Open Access
- 11 November 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (1)
Abstract
Modic type 1 and 2 changes (MC-1 and MC-2) are highly prevalent in individuals with chronic low back pain, yet the cellular and molecular mechanisms underlying vertebral endplate degeneration remain poorly defined. Here, we report that osteoclastogenesis is markedly elevated in MC-1 and MC-2 lesions compared with MC-3 lesions, suggesting an active role for osteoclasts in the early stages of degeneration. Using a lumbar spine instability (LSI) mouse model, we demonstrate enhanced osteoclast activity in degenerating endplates. RNA sequencing of mononuclear cells isolated from the endplate and adjacent subchondral bone identified Gdf15 as a potential upstream regulator of this process. Conditional knockout of Gdf15 in monocytes reduced osteoclast formation, aberrant CD31 hi Emcn hi angiogenesis, and pain-associated neurogenesis, ultimately mitigating endplate degeneration and mechanical allodynia. Mechanistically, GDF15 promoted the fusion of preosteoclasts by modulating the expression of Rho family small GTPases. In a humanized GDF15 knockin mouse model, therapeutic neutralization of GDF15 led to a reduction in osteoclast burden, improved endplate structure, and attenuated pain behavior. Together, these findings uncover a previously unrecognized role for GDF15 in driving osteoclast-mediated endplate degeneration and highlight its potential as a therapeutic target for the treatment of endplate-related chronic low back pain.Keywords
Funding Information
- National Natural Science Foundation of China (82201748)
- Shanghai Sailing Program (21YF1459200)
- National Natural Science Foundation of China (82571824)
- National Natural Science Foundation of China (82571824)
This publication has 68 references indexed in Scilit:
- Tumor‐Derived GDF15 Induces Tumor Associated Fibroblast Transformation From BMSCs and Fibroblasts in Oral Squamous Cell CarcinomaJournal of Cellular Physiology, 2024
- Intradiscal administration of autologous platelet‐rich plasma in patients with Modic type 1 associated low back pain: A prospective pilot studyJOR SPINE, 2024
- Phillygenin prevents osteoclast differentiation and bone loss by targeting RhoAPhytotherapy Research, 2024
- Effect of a Biopsychosocial Intervention or Postural Therapy on Disability and Health Care Spending Among Patients With Acute and Subacute Spine PainJAMA, 2022
- A definition and clinical grading of Modic changesJournal of Orthopaedic Research, 2021
- RETRACTED: Graphene‐Based MicroRNA Transfection Blocks Preosteoclast Fusion to Increase Bone Formation and VascularizationAdvanced Science, 2017
- Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM ExtensionJournal of Bone and Mineral Research, 2017
- Modic (endplate) changes in the lumbar spine: bone micro-architecture and remodellingEuropean Spine Journal, 2014
- Positive regulation of osteoclastic differentiation by growth differentiation factor 15 upregulated in osteocytic cells under hypoxiaJournal of Bone and Mineral Research, 2011
- Diagnosis and surgical treatment of back pain originating from endplateEuropean Spine Journal, 2009